EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia

Micah T Prochaska, Gerard T Portela, Maria Mori Brooks, Dean A Fergusson, Paul C Hébert, Tamar S Polonsky, Adriano Caixeta, Howard A Cooper, Ian Crozier, Benoit Daneault, Sarang Kim, Kevin R Bainey und 7 weitere

JAMA Internal Medicine · 2025

DOI: 10.1001/jamainternmed.2025.0654 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Internal Medicine, 2025. Verfasst von Micah T Prochaska und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Chicago, Chicago, Illinois. Hauptthemen laut MEDLINE: Quality of Life, Myocardial Infarction, Anemia, Erythrocyte Transfusion. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Both myocardial infarction (MI) and anemia have deleterious effects on health-related quality of life (QOL). Red blood cell (RBC) transfusion may improve QOL after MI by relieving symptoms and/or increasing functional capacity.

Objective

To evaluate whether a liberal transfusion strategy compared with a more restrictive transfusion strategy affects QOL in patients with MI and anemia. Design, Setting, and Participants This analysis of QOL as a prespecified secondary outcome of the Myocardial Ischemia and Transfusion (MINT) trial, a randomized clinical trial comparing a liberal vs restrictive RBC transfusion strategy, included participants from 144 sites across 6 countries. Hospitalized adults with acute MI and anemia (hemoglobin [Hb] less than 10 g/dL). The MINT trial randomized 3504 patients, and this analysis included those who had QOL data collected and those who died before the 30-day follow-up period. Data were collected from April 2017 to April 2023, and data were analyzed from February 2024 to January 2025.

Interventions

The MINT trial randomized patients to a restrictive (Hb of 7 to 8 g/dL) or a liberal (Hb of less than 10 g/dL) RBC transfusion strategy. Main Outcomes and Measures QOL was measured using the EQ-5D-5L 30 days after randomization.

Results

Of 2844 included patients, 1551 (54.5%) were male, and the mean (SD) age was 71.9 (11.5) years. A total of 2525 (88.8%; 1254 [49.7%] in the restrictive group and 1271 [50.3%] in the liberal group) had QOL data, and 319 (11.2%) died before 30-day follow-up. Overall, there were no differences in mean or median scores for any EQ-5D-5L QOL outcome between assigned transfusion strategies at 30 days postrandomization. Although a higher percentage of patients in the liberal compared with the restrictive transfusion group reported no problems compared with any problem in usual activities (506 of 1268 [39.9%] vs 473 of 1247 [37.9%]), mobility (474 of 1270 [37.3%] vs 460 of 1254 [36.7%]), and self-care (858 of 1271 [67.5%] vs 803 of 1254 [64.0%]) domains, none of these differences were statistically significant. Adjusted mixed-effects linear regressions showed no association between assigned transfusion strategy and mean differences in any QOL outcome. Adjusted regressions in several prespecified subgroups showed an association between a liberal transfusion strategy and better QOL scores in domains related to functional capacity, but the effects were only statistically significant in patients with a history of heart failure (Health Today rating: β, 2.06 [95% CI, −0.23 to 4.35] vs −1.44 [95% CI, −3.81 to 0.92]; P = .04). Conclusions and Relevance This secondary analysis of the MINT trial found that in patients with MI and anemia, a liberal transfusion strategy compared with a restrictive transfusion strategy did not affect QOL outcomes 30 days after randomization. This suggests that higher Hb levels maintained with RBC transfusion may not offer significant benefits to QOL overall in patients with MI and anemia. Additional studies may be useful for further examining and validating transfusion’s effect on QOL in patients with MI and heart failure. Trial Registration ClinicalTrials.gov Identifier: NCT02981407

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeMyocardial InfarctionAnemiaErythrocyte TransfusionHumansMaleFemaleAgedMiddle Aged

Autor:innen und Institutionen

  • Department of Medicine, University of Chicago, Chicago, Illinois.
  • Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Bruyere Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Medicine, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Department of Cardiology, New York Medical College, Valhalla, New York.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Prochaska, M. T., Portela, G. T., Brooks, M. M., Fergusson, D. A., Hébert, P. C., Polonsky, T. S., Caixeta, A., Cooper, H. A., Crozier, I., Daneault, B., Kim, S., Bainey, K. R., de Barros E Silva, P., Goldfarb, M., Gupta, R., Rao, S. V., Fonteles Ritt, L. E., Simon, T., & Carson, J. L. (2025). Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2025.0654

Vancouver

Prochaska MT, Portela GT, Brooks MM, Fergusson DA, Hébert PC, Polonsky TS, et al. Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia. JAMA Internal Medicine. 2025. doi:10.1001/jamainternmed.2025.0654

BibTeX
@article{Prochaska2025,
  author = {Prochaska, Micah T and Portela, Gerard T and Brooks, Maria Mori and Fergusson, Dean A and Hébert, Paul C and Polonsky, Tamar S and Caixeta, Adriano and Cooper, Howard A and Crozier, Ian and Daneault, Benoit and Kim, Sarang and Bainey, Kevin R and de Barros E Silva, Pedro and Goldfarb, Michael and Gupta, Rajesh and Rao, Sunil V and Fonteles Ritt, Luiz Eduardo and Simon, Tabassome and Carson, Jeffrey L},
  title = {Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia},
  journal = {JAMA Internal Medicine},
  year = {2025},
  doi = {10.1001/jamainternmed.2025.0654}
}
Kostenlos starten →